NCT00374192View on ClinicalTrials.gov

The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
MenopauseInsomnia
Interventions
DRUG

Eszopiclone

3 mg per day

DRUG

Placebo

Placebo

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00374192 - The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women | Biotech Hunter | Biotech Hunter